Tracked deals
10
10 tracked deals across 2021-2025.
Stamford, Connecticut, United States
Avesi Partners is a private equity group that partners with lower-middle market companies in Healthcare Services, Healthcare Technology, and Business Services. The firm focuses on control positions in companies with $5–30M EBITDA and $50–300M enterprise value, working with established teams to accelerate performance and support long-term growth.
Tracked deals
10
10 tracked deals across 2021-2025.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Growth capital
6 growth capital · 3 addon · 1 buyout
Last 5 years
Supporting Data
Avesi Partners has made its first institutional investment in Mosaic Consulting Group, a Nashville-based UKG-focused HCM and workforce management consulting and managed services provider. The minority strategic growth investment will partner with Mosaic's leadership to accelerate organic growth, expand managed services offerings, and support M&A-driven expansion.
AVS Bio, a portfolio company of Arlington Capital Partners, has acquired ImmunoPrecise Antibodies (Europe) B.V., a carve-out from ImmunoPrecise Antibodies Ltd. The acquisition expands AVS Bio's European footprint and adds antibody discovery, recombinant protein expression, and organoid growth factor development capabilities to its biologics services platform.
Sands Point Risk, a multi-program MGA platform backed by Avesi Partners, has acquired BRM Specialty Markets, a medical stop-loss managing general underwriter based in the Philadelphia area. BRM will continue to operate under its existing brand and leadership while gaining access to Sands Point's resources to support growth and scaling of its stop-loss underwriting capabilities.
Avesi Partners has made a growth investment in First Steps Recovery, a Fresno, California–based provider of substance use disorder (SUD) treatment. Avesi will partner with First Steps' management to support expansion of the company's continuum of care — including medical detox, residential treatment, PHP, IOP and telehealth — into additional geographies and care settings.
Avesi Partners has made a minority growth investment in Visante, a St. Paul–based provider of tech-enabled pharmacy consulting and services for health systems. The partnership will support Visante’s growth and capability expansion across specialty and infusion pharmacy markets and includes an internal leadership transition with Steve Rough named CEO and Jim Jorgenson moving to an advisory role.
memoryBlue, a portfolio company of Avesi Partners, has acquired Operatix (Operatix Ltd. and Operatix, Inc.) to form a global provider of outsourced sales development and sales acceleration services for B2B technology companies. The combination expands geographic coverage across North America, EMEA, LATAM and APAC, creates a combined team of 750+ employees, and retains Operatix leadership in senior roles as part of the integrated management team.
Avesi Partners has made a growth investment in Muir Wood, LLC, a Petaluma, California-based provider of adolescent-focused residential behavioral health services. The capital will support Muir Wood’s plan to expand into new geographies and add service lines while partnering with founder and CEO Scott Sowle and the existing management team.
Avesi Partners has made a growth investment in Point Quest, a Sacramento-based provider of adolescent behavioral health and special education services that primarily serves K-12 school districts in California. The investment will support Point Quest's plans to expand services, scale operations, and increase its geographic reach while partnering with the company's cofounders and management team.
Avesi Partners has made a growth investment in memoryBlue, an outsourced sales development and sales training firm headquartered in Tysons, Virginia. The investment will support memoryBlue's geographic expansion and broaden its service offerings while the co-founders remain partnered with the firm.
Avesi Partners has made a private equity investment in Danforth Advisors, with Stone‑Goff Partners exiting its stake. Danforth, headquartered in Waltham, Massachusetts, provides financial, operational and clinical business support to life science companies; the investment is intended to help scale the company's services, people and geographic footprint to meet growing demand in the life sciences market.
Turn tracked acquisition activity into an outreach-ready buyer list.